Why the industry needs to rethink its approach to IRT for smarter trials
Traditional approaches to Interactive Response Technology are falling short, with poorly designed systems hindering study start-ups, hampering agility, and frustrating users. In a recent webinar, experts discuss how to make IRT a strategic asset in your next clinical trial.
